New Low-Grade Brain-tumor Classification Uses Molecular and Genetic Analysis

A new system of tumor classification may lead to major improvements in diagnosis and treatment using molecular and genetic analysis to apply the latest innovations. Scientists from the Brain Tumor and Neuro-Oncology Center at University Hospitals Case Medical Center published their proposed system online in The New England Journal of Medicine. The collaboration, conducted via 43 different cancer centers, used the latest genetic testing methods and reduced the role of observation techniques, with refined classifications and recommendations for treatment options. “The findings demonstrate that these three groups of LGGs can be identified objectively by three different markers,” the lead author of the study said. “While various centers have been using some of these markers for years, this study helps validate these three markers as the accepted standards.” The Food and Drug Administration has already approved the methods involved in this system, allowing it to be implemented on a wider scale for testing. To learn more about this study, click here.